These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 18182242)
41. Vascular B1 kinin receptors in patients with congestive heart failure. Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823 [TBL] [Abstract][Full Text] [Related]
42. Potent, long-acting bradykinin antagonists for a wide range of applications. Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS Can J Physiol Pharmacol; 1997 Jun; 75(6):719-24. PubMed ID: 9276154 [TBL] [Abstract][Full Text] [Related]
43. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease. Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900 [TBL] [Abstract][Full Text] [Related]
44. Bifunctional ligands of the bradykinin B Marceau F; Bawolak MT; Fortin JP; Morissette G; Roy C; Bachelard H; Gera L; Charest-Morin X Peptides; 2018 Jul; 105():37-50. PubMed ID: 29802875 [TBL] [Abstract][Full Text] [Related]
45. From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists. Barth M; Bondoux M; Luccarini JM; Peyrou V; Dodey P; Pruneau D; Massardier C; Paquet JL J Med Chem; 2012 Mar; 55(6):2574-84. PubMed ID: 22369198 [TBL] [Abstract][Full Text] [Related]
46. Non-competitive pharmacological antagonism at the rabbit B(1) receptor. Larrivée JF; Gera L; Houle S; Bouthillier J; Bachvarov DR; Stewart JM; Marceau F Br J Pharmacol; 2000 Nov; 131(5):885-92. PubMed ID: 11053207 [TBL] [Abstract][Full Text] [Related]
47. Differential bradykinin B1 and B2 receptor regulation in cell death induced by hepatic ischaemia/reperfusion injury. Paio MA; Kouyoumdjian M; Borges DR; Nagaoka MR Clin Sci (Lond); 2014 Sep; 127(6):405-13. PubMed ID: 24724708 [TBL] [Abstract][Full Text] [Related]
48. Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor. Bélanger S; Bovenzi V; Côté J; Neugebauer W; Amblard M; Martinez J; Lammek B; Savard M; Gobeil F Peptides; 2009 Apr; 30(4):777-87. PubMed ID: 19111586 [TBL] [Abstract][Full Text] [Related]
49. The aggregation properties of some bradykinin analogs. Liu X; Stewart JM; Cann JR; Gera L; Kotovych G J Biomol Struct Dyn; 1993 Aug; 11(1):169-79. PubMed ID: 8216942 [TBL] [Abstract][Full Text] [Related]
50. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958. Hawkinson JE; Szoke BG; Garofalo AW; Hom DS; Zhang H; Dreyer M; Fukuda JY; Chen L; Samant B; Simmonds S; Zeitz KP; Wadsworth A; Liao A; Chavez RA; Zmolek W; Ruslim L; Bova MP; Holcomb R; Butelman ER; Ko MC; Malmberg AB J Pharmacol Exp Ther; 2007 Aug; 322(2):619-30. PubMed ID: 17470643 [TBL] [Abstract][Full Text] [Related]
51. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides. Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249 [TBL] [Abstract][Full Text] [Related]
52. Aspartic acid scaffold in bradykinin B1 antagonists. Huszár J; Timár Z; Bogár F; Penke B; Kiss R; Szalai KK; Schmidt E; Papp A; Keseru G J Pept Sci; 2009 Jun; 15(6):423-34. PubMed ID: 19378355 [TBL] [Abstract][Full Text] [Related]
54. BK2 but not BK1 receptors mediating contractile response in human umbilical arteries: role of thromboxane A2. Tiritilli A; El Habach T; Haury L; Duret JF Methods Find Exp Clin Pharmacol; 2004 May; 26(4):247-52. PubMed ID: 15319801 [TBL] [Abstract][Full Text] [Related]
55. A comparative NMR and molecular dynamics study of the conformations of bradykinin B1 and B2, B2, and B1-specific receptor antagonists B-9430, B-9436, and B-9858. Sejbal J; Wang Y; Cann JR; Stewart JM; Gera L; Kotovych G Biopolymers; 1997 Oct; 42(5):521-35. PubMed ID: 9322442 [TBL] [Abstract][Full Text] [Related]
56. The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors. Bawolak MT; Fortin JP; Vogel LK; Adam A; Marceau F Eur J Pharmacol; 2006 Dec; 551(1-3):108-11. PubMed ID: 17026984 [TBL] [Abstract][Full Text] [Related]
57. Bradykinin antagonists modified with dipeptide mimetic beta-turn inducers. Alcaro MC; Vinci V; D'Ursi AM; Scrima M; Chelli M; Giuliani S; Meini S; Di Giacomo M; Colombo L; Papini AM Bioorg Med Chem Lett; 2006 May; 16(9):2387-90. PubMed ID: 16504505 [TBL] [Abstract][Full Text] [Related]